NCT06771479View on ClinicalTrials.gov

A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine

PHASE1RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 22, 2025

Primary Completion Date

January 30, 2026

Study Completion Date

May 30, 2026

Conditions
Monkeypox
Interventions
BIOLOGICAL

MVA strain monkeypox attenuated live vaccine (low dose)

Low dose MVA strain monkeypox attenuated live vaccine

BIOLOGICAL

MVA strain monkeypox attenuated live vaccine (high dose)

High dose MVA strain monkeypox attenuated live vaccine

OTHER

Placebo

Vaccine excipient

Trial Locations (1)

Unknown

RECRUITING

Henan Infectious Disease Hospital, Zhengzhou

All Listed Sponsors
lead

Shanghai Institute Of Biological Products

INDUSTRY